Alzheimer Disease 1
6
0
2
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Progress of Mild Alzheimer's Disease in Participants on Acupuncture Versus Sham Acupuncture
A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)
Brain Health & the Microbiome
Safety and Feasibility of Exablate Blood-Brain Barrier Disruption for Mild Cognitive Impairment or Mild Alzheimer's Disease Undergoing Standard of Care Monoclonal Antibody (mAb) Therapy
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Alzheimer's Disease
Study of APH-1105 in Patients With Mild to Moderate Alzheimer's Disease